Literature DB >> 32215884

A Gene-Based Classification of Primary Adrenocortical Hyperplasias.

Fady Hannah-Shmouni1, Constantine A Stratakis1.   

Abstract

Primary or adrenocorticotropin-independent adrenocortical tumors and hyperplasias represent a heterogeneous group of adrenocortical neoplasms that arise from various genetic defects, either in isolation or familial. The traditional classification as adenomas, hyperplasias, and carcinomas is non-specific. The recent identification of various germline and somatic genes in the development of primary adrenocortical hyperplasias has provided important new insights into the molecular pathogenesis of adrenal diseases. In this new era of personalized care and genetics, a gene-based classification that is more specific is required to assist in the understanding of their disease processes, hormonal functionality and signaling pathways. Additionally, a gene-based classification carries implications for treatment, genetic counseling and screening of asymptomatic family members. In this review, we discuss the genetics of benign adrenocorticotropin-independent adrenocortical hyperplasias, and propose a new gene-based classification system and diagnostic algorithm that may aid the clinician in prioritizing genetic testing, screening and counseling of affected, at risk individuals and their relatives. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Year:  2020        PMID: 32215884     DOI: 10.1055/a-1107-2972

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  9 in total

Review 1.  Adrenocortical tumorigenesis: Lessons from genetics.

Authors:  Crystal D C Kamilaris; Fady Hannah-Shmouni; Constantine A Stratakis
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2020-05-23       Impact factor: 4.690

2.  Volumetric Modeling of Adrenal Gland Size in Primary Bilateral Macronodular Adrenocortical Hyperplasia.

Authors:  Rachel Wurth; Amit Tirosh; Crystal D C Kamilaris; Jancarlos Camacho; Fabio R Faucz; Andrea Gutierrez Maria; Annabel Berthon; Georgios Z Papadakis; Naris Nilubol; Ahmed Hamimi; Ahmed M Gharib; Andrew Demidowich; Mihail Zilbermint; Graeme Eisenhofer; Leah Braun; Martin Reincke; Constantine A Stratakis; Fady Hannah-Shmouni
Journal:  J Endocr Soc       Date:  2020-10-29

Review 3.  Genetic Alterations in Benign Adrenal Tumors.

Authors:  Georgia Pitsava; Constantine A Stratakis
Journal:  Biomedicines       Date:  2022-04-30

4.  c-KIT oncogene expression in PRKAR1A-mutant adrenal cortex.

Authors:  Kiran Nadella; Fabio R Faucz; Constantine A Stratakis
Journal:  Endocr Relat Cancer       Date:  2020-10       Impact factor: 5.678

5.  Cushing Syndrome in a Pediatric Patient With a KCNJ5 Variant and Successful Treatment With Low-dose Ketoconazole.

Authors:  Christina Tatsi; Andrea G Maria; Cole Malloy; Lin Lin; Edra London; Nick Settas; Chelsi Flippo; Meg Keil; Fady Hannah-Shmouni; Dax A Hoffman; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2021-05-13       Impact factor: 5.958

6.  Insulin-like growth factor 2 (IGF2) expression in adrenocortical disease due to PRKAR1A mutations compared to other benign adrenal tumors.

Authors:  Kiran S Nadella; Annabel Berthon; Madson Q Almeida; Isaac Levy; Fabio R Faucz; Constantine A Stratakis
Journal:  Endocrine       Date:  2021-01-09       Impact factor: 3.633

7.  ARMC5 variants in PRKAR1A-mutated patients modify cortisol levels and Cushing's syndrome.

Authors:  Andrea Gutierrez Maria; Christina Tatsi; Annabel Berthon; Ludivine Drougat; Nikolaos Settas; Fady Hannah-Shmouni; Jerome Bertherat; Fabio R Faucz; Constantine A Stratakis
Journal:  Endocr Relat Cancer       Date:  2020-09       Impact factor: 5.900

Review 8.  Molecular Genetic and Genomic Alterations in Cushing's Syndrome and Primary Aldosteronism.

Authors:  Crystal D C Kamilaris; Constantine A Stratakis; Fady Hannah-Shmouni
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-12       Impact factor: 5.555

9.  Phosphodiesterase 2A and 3B variants are associated with primary aldosteronism.

Authors:  Marcela Rassi-Cruz; Andrea G Maria; Fabio R Faucz; Edra London; Leticia A P Vilela; Lucas S Santana; Anna Flavia F Benedetti; Tatiana S Goldbaum; Fabio Y Tanno; Vitor Srougi; Jose L Chambo; Maria Adelaide A Pereira; Aline C B S Cavalcante; Francisco C Carnevale; Bruna Pilan; Luiz A Bortolotto; Luciano F Drager; Antonio M Lerario; Ana Claudia Latronico; Maria Candida B V Fragoso; Berenice B Mendonca; Maria Claudia N Zerbini; Constantine A Stratakis; Madson Q Almeida
Journal:  Endocr Relat Cancer       Date:  2021-01       Impact factor: 5.678

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.